US$ 22.66
tirzepatide preço drogasil Photo by Araxá Getúlio Vargas (@drogasilaraxagetuliovargas) · April 9, 2026 Mounjaro faz Raia Drogasil (RADL3)
Description
They review your health history and deliver your product quickly
/i.s3.glbimg.com/v1/AUTH_f035dd6fd91c438fa04ab718d608bbaa/internal_photos/bs/2023/o/H/CAsjbTQsKFJZpepVXz9g/tirzepatida-20mounjaro.jpg)
Provider comparison table No single provider is objectively "the best." The right choice depends on your priorities
Real-world results are somewhat lower for both medications but the advantage for tirzepatide holds in practice, not just in studies

Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes CONCENTRATION CONCENTRATION CONCENTRATION CONCENTRATION CONCENTRATION Tirzepatide Tirzepatide Tirzepatide Tirzepatide Tirzepatide 60mg/3mL 60mg/3mL 60mg/3mL 60mg/3mL PHARMACEUTICAL FORM PHARMACEUTICAL FORM PHARMACEUTICAL FORM PHARMACEUTICAL FORM PHARMACEUTICAL FORM Injectable solution Injectable solution Injectable solution Injectable solution Injectable solution 1 vial 60 mg of Tirzepatide (Lyophilized Powder) 1 vial 3 ml of bacteriostatic water 1 vial 60 mg of Tirzepatide (Lyophilized Powder) 1 vial 3 ml of bacteriostatic water Efficacy Tirzepatide is a dual agonist of the GIP and GLP-1 receptors, designed to enhance glycemic control in patients with type 2 diabetes

Patients should be aware of the signs and symptoms of hypoglycemia (see hypoglycemia)
